Company News: Eli Lilly & Co.

Share this article:

Lilly chief John Lechleiter called for a shift in thinking on healthcare reform “from an emphasis on cost to an understanding of value … and from thinking in terms of the broad population to focusing on meeting the needs of individual patients.” The emphasis on cost is misguided, he said, because it can increase health spending over time by slowing or blocking the flow of new medicines to market.

Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.